Anant Pharmaceuticals
Anant Pharmaceuticals, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and formulations. Founded in 2005, the company has established a strong presence in key operational regions, including Asia, Europe, and North America. With a commitment to innovation, Anant Pharmaceuticals offers a diverse range of products, including generic medicines and custom synthesis services, distinguished by their adherence to stringent quality standards. The company has achieved significant milestones, including regulatory approvals from major global health authorities, solidifying its market position as a trusted supplier in the pharmaceutical sector. Anant Pharmaceuticals continues to focus on expanding its portfolio and enhancing its capabilities to meet the evolving needs of the healthcare industry.
DitchCarbon Score
How does Anant Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Anant Pharmaceuticals's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Anant Pharmaceuticals's reported carbon emissions
Anant Pharmaceuticals, headquartered in India, currently does not have publicly available data on its carbon emissions, including specific figures for Scope 1, 2, or 3 emissions. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This absence of data suggests that Anant Pharmaceuticals may still be in the early stages of formalising its climate commitments or reporting practices. As the pharmaceutical industry increasingly prioritises sustainability, it will be essential for Anant Pharmaceuticals to establish clear emissions reduction goals and strategies to align with global climate initiatives.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Anant Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
